围脂滴蛋白基因CRISPR/Cas9载体的活性分析

doi:10.13560/j.cnki.biotech.bull.1985.2019-0357

生物技术通报 ›› 2019, Vol. 35 ›› Issue (11): 89-95.doi: 10.13560/j.cnki.biotech.bull.1985.2019-0357

围脂滴蛋白基因CRISPR/Cas9载体的活性分析

许祥¹, 董维鹏¹, 张少华¹, 冯晨毅¹, 刘田福², 燕炯¹

1.山西医科大学公共卫生学院,太原 030001;
2.山西医科大学动物实验中心,太原 030001

收稿日期:2019-04-22 出版日期:2019-11-26 发布日期:2019-11-19
作者简介:许祥,男,硕士研究生,研究方向：肥胖相关疾病分子学;E-mail：1079269247@qq.com
基金资助:
山西省国际科技合作项目（2014081050-1）,山西省实验动物资源共享服务平台,山西医科大学科技创新基金项目（01201504）

Construction and Activity Analysis of the PLIN1 Gene CRISPR/Cas9 Vector

XU Xiang¹, DONG Wei-peng¹, ZHANG Shao-hua¹, FENG Chen-yi¹, LIU Tian-fu², YAN Jiong¹

1. School of Public Health,Shanxi Medical University,Taiyuan 030001;
2. Laboratory Animal Center of Shanxi Medical University,Shanxi Medical University,Taiyuan 030001

Received:2019-04-22 Published:2019-11-26 Online:2019-11-19

摘要/Abstract

摘要：

设计并验证能够靶向切割PLIN1基因的sgRNA,为建立高效的PLIN1基因敲除动物模型奠定基础。利用预测软件设计3条评分较好的sgRNA。添加T7启动子后体外转录相应的sgRNA,构建酶切体系并验证其体外切割活性。构建相应的基因敲除质粒载体,通过电转染将质粒转到3T3-L1前脂肪细胞内并进行诱导分化。RT-PCR法检测细胞中PLIN1 mRNA的表达,Western blot法检测细胞中PLIN1蛋白的表达。成功在体外转录3条PLIN1的sgRNA并构建酶切体系,测得sgRNA-PLIN1-1的切割效率为61.8%±9.0%,sgRNA-PLIN1-2的切割效率为64.1%±9.6%,sgRNA-PLIN1-3的切割效率为34.1%±7.2%,sgRNA-PLIN1-3组的切割效率明显低于sgRNA-PLIN1-1组和sgRNA-PLIN1-2组（P<0.05）。成功构建3条sgRNA的质粒载体并电转染进入3T3-L1前脂肪细胞内,转染效率约为30%。诱导分化的第4天,各阳性干扰组PLIN1 mRNA的表达量显著降低（P<0.01）;与sgR NA-PLIN1-3组相比,sgRNA-PLIN1-1组和sgRNA-PLIN1-2组PLIN1 mRNA的表达量有显著性差异;各阳性干扰组PLIN1蛋白的表达量显著降低（P<0.01）,阳性干扰组相互之间PLIN1蛋白的表达量无显著性差异。3条sgRNA皆可以靶向切割PLIN1基因的2号外显子,其中gRNA-PLIN1-1组和sgRNA-PLIN1-2组的切割活性略高于sgRNA-PLIN1-3组。体外活性切割实验可以很好的预测细胞内切割效果,是筛选高活性sgRNA的有效手段。

关键词: PLIN1基因, CRISPR/Cas9, sgRNA, 载体构建, 切割效率

Abstract:

The objectives of this work are to design and validate the sgRNA being capable of targeted cleaving the PLIN1 gene and to lay a foundation for the establishment of a highly efficient PLIN1 gene-cleaved animal model. Three sgRNAs with favorable evaluation results were designed using predictive software. After adding T7 promoter,the corresponding sgRNA was transcribed in vitro to construct the digestive system and to verify the cleavage activity in vitro. The corresponding gene knockout plasmid vector was constructed,and the plasmid was transferred into 3T3-L1 preadipocytes by electroporation and induced to differentiate. The expression of PLIN1 mRNA in cells was detected by RT-PCR. The expression of PLIN1 protein in cells was detected by Western blot. Three sgRNAs of PLIN1 were successfully transcribed in vitro and the restriction enzyme system was constructed. The cleavage efficiency of sgRNA-PLIN1-1 was 61.8%±9.0%,and that of sgRNA-PLIN1-2 was 64.1%±9.6%. The cleavage efficiency of sgRNA-PLIN1-3 was 34.1%±7.2%,and that of sgRNA-PLIN1-3 group was significantly lower than that of sgRNA-PLIN1-1 group and sgRNA-PLIN1-2 group（P<0.05）. The plasmid vector of three sgRNAs was successfully constructed and electroporated into 3T3-L1 preadipocytes,and the transfection efficiency was about 30%. The expression of PLIN1 mRNA in each positive interference group（P<0.01）significantly decreased at the 4th day after differentiation. Compared with sgRNA-PLIN1-3 group,there was a significant difference in the expression level of PLIN1 mRNA in sgRNA-PLIN1-1 group and sgRNA-PLIN1-2 group. The expression of PLIN1 protein in each positive interference group significantly decreased（P<0.01）,and there was no significant difference in the expression of PLIN1 protein between the positive interference groups. In conclusion,all three sgRNAs may cleave the exon 2 of the PLIN1 gene in a target manner,and the cleavage activity of the gRNA-PLIN1-1 group and the sgRNA-PLIN1-2 group is slightly higher than that of the sgRNA-PLIN1-3 group. In vitro active cleavage experiments may well predict intracellular cleavage and are an effective means of screening highly active sgRNA.

Key words: PLIN1 gene, CRISPR/Cas9, sgRNA, vector construction, cleavage efficiency

许祥, 董维鹏, 张少华, 冯晨毅, 刘田福, 燕炯. 围脂滴蛋白基因CRISPR/Cas9载体的活性分析[J]. 生物技术通报, 2019, 35(11): 89-95.

XU Xiang, DONG Wei-peng, ZHANG Shao-hua, FENG Chen-yi, LIU Tian-fu, YAN Jiong. Construction and Activity Analysis of the PLIN1 Gene CRISPR/Cas9 Vector[J]. Biotechnology Bulletin, 2019, 35(11): 89-95.

参考文献

[1] Hryhorowicz M, Lipiński, D, et al.CRISPR/Cas9 immune system as a tool for genome engineering[J]. Archivum Immunologiae et Therapiae Experimentalis, 2017, 65(3):233-240.
[2] Cong L, Ran FA, Cox D, et al.Multiplex genome engineering using CRISPR/Cas systems[J]. Science, 2013, 339:819-823.
[3] Zhang H, Mccarty N.CRISPR editing in biological and biomedical investigation[J]. Journal of Cellular Biochemistry, 2017, 118(12):4152-4162.
[4] Xu H, Xiao TF, Chen CH, et al.Sequence determinants of improved CRISPR sg RNA design[J]. Genome Res, 2015, 25:1147-1157.
[5] Tsai SQ, Zheng Z, Nguyen NT, et al.GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases[J]. Nat Biotechnol, 2015, 33:187-197.
[6] Farboud B, Meyer BJ.Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design[J]. Genetics, 2015, 199(4):959-971.
[7] Brasaemle DL.Thematic review series:adipocyte biology. The perilipin family of structural lipid droplet proteins:stabilization of lipid droplets and control of lipolysis[J]. J Lipid Res, 2007, 48(12):2547-2559.
[8] Brasaemle DL, Wolins NE.Packaging of fat:an evolving model of lipid droplet assembly and expansion[J]. J Biol Chem, 2012, 287(4):2273-2279.
[9] Sztalryd C, Kimmel AR.Perilipins:lipid droplet coat proteins adapted for tissue specific energy storage and utilization, and lipid cytoprotection[J]. Biochimie, 2014, 96:96-101.
[10] Zou L, Wang W, Liu S, et al.Spontaneous hypertension occurs with adipose tissue dysfunction in perilipin-1 null mice[J]. Biochim Biophys Acta, 2016, 1862(2):182-191.
[11] Nishimasu H, et al.Crystal structure of Cas9 in complex with guide RNA and target DNA[J]. Cell, 2014, 156(5):935-949.
[12] 王威仪, 张彬, 季汉华, 等. 脂滴与心力衰竭的研究进展[J]. 生理科学进展, 2018(1). 69-73.
[13] Zetsche B, Gootenberg JS, Abudayyeh OO, et al.Cpf1 is a single RNA-Guided endonuclease of a class 2 CRISPR-Cas system.[J]. Cell, 2015, 163(3):759-771.
[14] 吴曦, 周舒雅, 刘甦苏等. 高效切割Hipp11敲入位点的sgRNA设计及活性验证[J]. 实验动物科学, 2015, 32(5):26-30.

[1]	陈小玲, 廖东庆, 黄尚飞, 陈英, 芦志龙, 陈东. 利用CRISPR/Cas9系统改造酿酒酵母的研究进展[J]. 生物技术通报, 2023, 39(8): 148-158.
[2]	杨玉梅, 张坤晓. 应用CRISPR/Cas9技术建立ERK激酶相分离荧光探针定点整合的稳定细胞株[J]. 生物技术通报, 2023, 39(8): 159-164.
[3]	施炜涛, 姚春鹏, 魏文康, 王蕾, 房元杰, 仝钰洁, 马晓姣, 蒋文, 张晓爱, 邵伟. 利用CRISPR/Cas9技术构建MDH2敲除细胞株及抗呕吐毒素效应研究[J]. 生物技术通报, 2023, 39(7): 307-315.
[4]	刘晓燕, 祝振亮, 史广宇, 华梓宇, 杨晨, 张涌, 刘军. 乳腺生物反应器的表达优化策略[J]. 生物技术通报, 2023, 39(5): 77-91.
[5]	程静雯, 曹磊, 张艳敏, 叶倩, 陈敏, 谭文松, 赵亮. CHO细胞多基因工程改造策略的建立及应用[J]. 生物技术通报, 2023, 39(2): 283-291.
[6]	黄文莉, 李香香, 周炆婷, 罗莎, 姚维嘉, 马杰, 张芬, 沈钰森, 顾宏辉, 王建升, 孙勃. 利用CRISPR/Cas9技术靶向编辑青花菜BoZDS[J]. 生物技术通报, 2023, 39(2): 80-87.
[7]	王兵, 赵会纳, 余婧, 陈杰, 骆梅, 雷波. 利用CRISPR/Cas9系统研究REVOLUTA参与烟草叶芽发育的调控[J]. 生物技术通报, 2023, 39(10): 197-208.
[8]	李双喜, 华进联. 抗猪繁殖与呼吸障碍综合征基因编辑猪研究进展[J]. 生物技术通报, 2023, 39(10): 50-57.
[9]	林蓉, 郑月萍, 徐雪珍, 李丹丹, 郑志富. 拟南芥ACOL8基因在乙烯合成与响应中的功能分析[J]. 生物技术通报, 2023, 39(1): 157-165.
[10]	刘静静, 刘晓蕊, 李琳, 王盈, 杨海元, 戴一凡. 利用CRISPR/Cas9技术建立OXTR基因敲除猪胎儿成纤维细胞系[J]. 生物技术通报, 2022, 38(6): 272-278.
[11]	Olalekan Amoo, 胡利民, 翟云孤, 范楚川, 周永明. 利用基因编辑技术研究BRANCHED1参与油菜分枝过程的调控[J]. 生物技术通报, 2022, 38(4): 97-105.
[12]	丁亚群, 丁宁, 谢深民, 黄梦娜, 张昱, 张勤, 姜力. Vps28基因敲除小鼠模型的构建及其对泌乳和免疫性状影响的研究[J]. 生物技术通报, 2022, 38(3): 164-172.
[13]	燕炯, 冯晨毅, 高学坤, 许祥, 杨佳敏, 陈朝阳. 基于CRISPR/Cas9技术构建Plin1基因敲除小鼠模型及表型分析[J]. 生物技术通报, 2022, 38(3): 173-180.
[14]	刘萌萌, 韩立军, 刘宝玲, 薛金爱, 李润植. 陆地棉GhSDP1及其启动子的克隆与表达分析[J]. 生物技术通报, 2022, 38(2): 34-43.
[15]	钟菁, 孙玲玲, 张姝, 蒙园, 支怡飞, 涂黎晴, 徐天鹏, 濮黎萍, 陆阳清. 应用CRISPR/Cas9技术敲除Mda5基因对新城疫及传染性法氏囊病毒复制的影响[J]. 生物技术通报, 2022, 38(11): 90-96.

围脂滴蛋白基因CRISPR/Cas9载体的活性分析

Construction and Activity Analysis of the PLIN1 Gene CRISPR/Cas9 Vector

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价